Business Context and Reporting Period
This Form 8-K filing by Gossamer Bio, Inc. (GOSS) reports on the results of the annual meeting of stockholders held on June 10, 2019. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Election of Directors: Three Class I directors were re-elected for a three-year term expiring in 2022.
- Sheila Gujrathi, M.D.: 51,757,618 votes For; 2,255,295 Withheld; 1,538,317 Broker Non-Votes.
- Kristina Burow: 51,579,058 votes For; 2,433,855 Withheld; 1,538,317 Broker Non-Votes.
- Thomas Daniel, M.D.: 52,248,317 votes For; 1,764,596 Withheld; 1,538,317 Broker Non-Votes.
- Ratification of Auditors: The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019, was ratified.
- Votes For: 55,532,378
- Votes Against: 4
- Abstain: 18,848
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Important Facts for Investors to Verify
- Confirmation that the three Class I directors were successfully re-elected with significant majority support.
- Verification that Ernst & Young LLP remains the independent auditor for the 2019 fiscal year.
- Review of the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.